While the pR5 mice display memory impairment as a major clinical feature of AD, another feature, Parkinsonism, that characterizes a significant subset of FTLD cases, has been modeled in K369I mutant tau transgenic K3 mice. The gene discussed is MAPT; the disease is Parkinsonism.